최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기藥劑學會誌 = Journal of Korean pharmaceutical sciences, v.33 no.3, 2003년, pp.223 - 227
최준식 (조선대학교 약학대학) , 박복순 (조선대학교 약학대학)
The purpose of this study was to investigate the effect of ketoconazole (20 mg/kg) on the pharmacokinetic parameters and the bioavailability of paclitaxel (40 mg/kg) orally coadministered in rats. The plasma concentration of paclitaxel in combination with ketoconazole was significantly (p<0.05) incr...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
A.E. Mathew, M.R. Mejillano, J.P. Nath, R.H. Himes and V.J. Stella, Synthesis and evaluation of some water-soluble prodrugs and derivatives of taxol with antitumor activity, J. Med. Chem., 35(1), 145-151 (1992)
P.M. Chaudhary and I.B. Robinson, Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells. Cell, 66, 85-94 (1991)
J.A. Endicott and V. Ling, The biochemistry of P-glycoprotein- mediated multidrug resistance, Annu. Rev. Biochem., 58, 137-171 (1989)
A. Rahman, K.R. Korzekwa, J. Grogan, F.J. Gonzalez and J.W. Harris, Selective biotransformation of taxol to 6-hydroxytaxol by human cytochrome P450 2C8., Cancer Res., 54, 5543-5548 (1994)
D.S. Sonnichsen, Q. Liu, E.G, Schuetz, J.D. Schuetz, A. Pappo and M.V. ReIling, Variability in human cytochrome P450 paclitaxel metabolism., J. Pharmacol. Exp. Ther., 275, 566-571 (1995)
T. Walle, Short communication, Taxol metabolism in rat hepatocytes. Biochem. Pharmacol., 46(9), 1661-1664 (1993)
D.S. Sonnichsen and M.V. ReIling, Clinical Pharmacokinetics of Paclitaxel, Clin. Phannacokinet., 27(4), 256-269 (1994)
G.A. Fisher and B.I. Sikic, Clinical studies with modulators of multidrug resistance. Hematol. Oncol. Clin. North Am., 9(2), 363-382 (1995)
E. Hofsli and J.N. Meyer, Reversal of multidrug resistance by lipophilic drugs, Cancer Res., 50, 3997-4002 (1990)
L.J. Bain, J.B. McLanchlan and G.A. LeBanc, Structureactivity relationship for xenobiotic transport substrates and inhibitory ligands of p-glycoprotein, Enviromental Health Perspectives, 105(8), 812-818 (1997)
T. Cresteil, B. Monsarrat, P. Alvinerid, J.M. Treluyer, I. Vieira and M. Wright. Taxol metabolism by human liver microsomes, identification of cytochrome P450 isozymes involved in its biotransformation, Cancer Res., 54, 386-395 (1994)
J.W. Harris, A. Rahman, B.R. Kim, F.P. Guengerich and J.M. Collins, Metabolism of taxol by human hepatic microsomes and liver slices, participation of cytochrome P450 3A4 and an unknown P450 enzyme, Cancer Res., 54, 4026-4031 (1994)
E.J. Wang, K. Lew, C.N. Casciano, R.P. Clement and W.W. Johnson, Interaction of common azole antifungals with P glycoprotein, Antimicrab. Agents Chemother, 46(1), 160-165 (2002)
E.J. Wang, C.N. Casciano, R.P. Clement and W.W Johnson, HMG-CoA reductase inhibitors (statins) characterized as direct inhibitors of P-glycoprotein, Pharm. Res., 18, 800-806 (2001)
I. Hsu, S.A. Spinler and N.E. Johnson, Comparative evaluation of the safety and efficacy of HMG-CoA reductase inhibitor monotherapy in the treatment of primary hypercholesterolemia, Ann. Pharmacother., 29, 743-759 (1995)
A. Bohme, A. Ganser and D. Hoelzer, Aggravation of vincristine-induced neurotoxicity by itraconazole in the treatment of adult, ALL. Ann. Hematol., 71, 311-312 (1995)
S. Gupta, J. Kim and S. Gollapudi, Reversal of daunorubicin resistance in P388/ADR cells by itraconazole, J. Clin. Investig., 87, 1467-1469 (1991)
G. Vreugdenhil, J.M. Raemaekers, B.J. Dijke, van and B.E. Pauw, de Itraconazole and multidrug resistance, possible effects on remission rate and disease-free survival in acute leukemia, Ann. Hematol., 67, 107-109 (1993)
K.M. Kaukonen, K.T. Olkkola and P.J. Neuvonen, Itraconazole increases plasma concentrations of quinidine, Clin. Pharmacol. Ther., 62, 510-517 (1997)
K.M. Jalava, J. Partanen and P.J. Neuvonen, Itraconazole decreases renal clearance of digoxin, Ther. Drug Monit., 19, 609-613 (1997)
J.M. Poirier and G. Cheymol, Optimisation of itraconazole therapy using target drug concentrations, Clin. Pharmacokinet., 35, 461-473 (1998)
D. Debruyne, Clinical pharmacokinetics of fluconazole in superficial and systemic mycoses, Clin. Pharmacokinet., 33, 52-77 (1997)
K. Venkatakrishnan, L.L. von Moltke and D.J. Greenblatt, Effects of the antifungal agents on oxidative drug metabolism, clinical relevance, Clin. Pharmacokinet., 38, 111-180 (2000)
J. Combalbert, I. Fabre and G. Fabre, et al., Metabolism of cyclosprrine A, IV : purification and identification of the rifampicin-inducible human liver cytochrome P-450 (cyclosporin A oxidase) as a product of P450A gene subfamily, Drug Metab. Disprs., 17, 197-207 (1989)
T. Kronbach, V. Fischer and U.A. Meyer, Cyclosprrine metabolism in human liver, identification of a cytochrome P450 gene family as the major cyclosporine with other drugs, Clin. Pharmacol. Ther., 43, 630-635 (1988)
J.C. Korars, P. Schmiedlin-Ren, J.D. Cchuetz, C. Fang and P.B. Watkins, Identification of rifampin-inducible P450A4 (CYP3A4) in human small bowel enterocytes, J. Clin. Invest., 90, 1871-1878 (1992)
J.C. Korars, W.M. Awni, P.M. Merion and P.B. Watkins, Firstpass metabolism of cyclosporin by the gut, Lancet, 338, 1488-1490 (1991)
D.Y. Gomez, V.J. Wacher, S.J. Tomlanovich, M.F. Hebert and L.Z. Benet, The effects of ketoconazole on the intestinal metabolism and bioavailability of cyclosporine, Clin. Pharmacol. Ther., 58(1), 15-19 (1995)
K.M. Kaukonen, K.T. Olkkola and P.J. Neuvonen, Itraconazole increases plasma concentrations of quinidine, Clin. Pharmacol. Ther., 62(5), 510-517 (1997)
N. Manrin, J. Catalin, M.F. Blachon and A. Durand, Assay of paclitaxel (Taxol) in plasma and urine by High Performance Liquid Chromatogrphy, J. Chromato. B., 709, 281-288 (1998)
H. Mase, M. Hiraoka and F. Suzuki, Determination of New Anticancer Drug, Paclitaxel, in Biological Fluids by High Performance Liquid Chromatography, Yakugaku. Zasshi., 114(5), 351-355 (1994)
K. Yamaoka, Y. Tanigawara, T. Nakagawa and T. Uno, A pharmacokinetics analysis program for microcomputer, J. Pham. Dyn., 4, 79-883 (1981)
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.